Practice Contact Information
Hollings Cancer Center, Medical University of South Carolina
135 Rutledge Avenue
Charleston
SC
29425
United States
Phone: 843-792-8363
Email: headneck@musc.edu
Web Site: http://www.hollingscancercenter.org/patient-care/cancer-types/head-neck/index.html
Areas of surgical specialization in Head and Neck Surgery
Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery
Biography/Statement
Dr. Terry Day received his medical degree from the University of Oklahoma. He completed his residency at Louisiana State University before pursuing a fellowship in head and neck oncologic surgery at the University of California, Davis and in craniomaxillofacial surgery at Inselspital-Bern in Bern, Switzerland. Following fellowship, he joined the faculty in the Department of Otolaryngology — Head and Neck Surgery at Vanderbilt University Medical Center in Nashville, Tennessee and is now professor, vice chair and director of the Division of Head and Neck Oncologic Surgery in the Department of Otolaryngology — Head and Neck Surgery at the Medical University of South Carolina in Charleston. He also serves as director of the head and neck tumor center at the NCI-designated Hollings Cancer Center at MUSC and has a joint appointment in the Department of Craniofacial Biology, Department of Stomatology and College of Graduate Studies.
Currently, he is U.S. National Director of Head and Neck Oncology for Sarah Cannon and his clinical practice is with Head and Neck Specialists in Charleston, SC. Previously he served as the Wendy & Keith Wellin Endowed Professor and Director of the Division of Head and Neck Oncologic Surgery in the Department of Otolaryngology-Head and Neck Surgery.
Dr. Day was the inaugural Director of the Head and Neck Tumor Center at Hollings Cancer Center, and Chair of the Coordinating Council of the statewide South Carolina Cancer Alliance. He currently serves as a member of the American Joint Committee on Cancer(AJCC) Education Committee. He served as the president of the American Head and Neck Society, chaired the committee on Head and Neck Surgery and Oncology for the American Academy of Otolaryngology-Head and Neck Surgery, and the Prevention Committee for the American Head and Neck Society. He also served on the Head and Neck Surgical Subcommittee for RTOG and Head and Neck Working Group for the American College of Surgeons Oncology Group. Dr. Day volunteers his time as Chairman of the Board of the Head and Neck Cancer Alliance and which leads the international Oral, Head and Neck Cancer Awareness Week annually.
Since completion of his fellowship, Dr. Day has limited his clinical practice to patients with tumors of the head and neck region, including robotic surgery, oropharyngeal, skull base, thyroid, skin cancer, and salivary gland tumors. He also is active in research in molecular diagnostics and therapeutics in head and neck cancer.
Clinical Trials
http://www.hollingscancercenter.org/clinical-trials/
Bibliography
PubMed